Dr. Barbosa is director of North Texas Joint Care, PA, in Dallas.
References
- Cohen SB, Emery P, Greenwald MW, et al. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum. 2006;54:2793-806.
- Schoels M, Knevel R, Aletaha D, et al. Evidence for treating rheumatoid arthritis to target: Results of a systematic literature search. Ann Rheum Dis. 2010;69:638-643.
- Texas Administrative Code. Title 22: Examining Boards, Part 9: Texas Medical Board, Chapter 165: Medical Records, Rule §165.2, Medical Record Release and Charges.